Inventor · disambiguated record
Srinivansan Venkateshwaran
Also filed as: VENKATESHWARAN SRINIVANSAN
18 granted patents·20 pending applications·255 citations·filing 2010–2020
96Inventor score
Top patents by PatentIndex Score
38 records- 0199US9480690B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2015·Granted Nov 1, 2016·34 cites·24 claims
- 0298US10973833B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2019·Granted Apr 13, 2021·8 cites·25 claims
- 0398US10881671B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2020·Granted Jan 5, 2021·5 cites·30 claims
- 0498US10716794B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2018·Granted Jul 21, 2020·9 cites·27 claims
- 0598US10226473B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2018·Granted Mar 12, 2019·23 cites·21 claims
- 0698US9949985B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Granted Apr 24, 2018·23 cites·26 claims
- 0798US9943527B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Granted Apr 17, 2018·18 cites·19 claims
- 0898US9757390B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Granted Sep 12, 2017·27 cites·27 claims
- 0998US9205057B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2015·Granted Dec 8, 2015·42 cites·26 claims
- 1097US10799513B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2018·Granted Oct 13, 2020·6 cites·7 claims
- 1197US9034858B2High-strength testosterone undecanoate compositionsGILIYAR CHANDRASHEKAR·Filed 2012·Granted May 19, 2015·47 cites·27 claims
- 1292US9358299B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2015·Granted Jun 7, 2016·7 cites·28 claims
- 1389US11364250B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2020·Granted Jun 21, 2022·1 cites·26 claims
- 1487US11364249B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2020·Granted Jun 21, 2022·1 cites·14 claims
- 1587US11311555B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2020·Granted Apr 26, 2022·1 cites·25 claims
- 1684US9066942B2Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerSPRIASO LLC·Filed 2014·Granted Jun 30, 2015·2 cites·9 claims
- 1783US11433083B2High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2019·Granted Sep 6, 2022·1 cites·13 claims
- 1876US11471470B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2020·Granted Oct 18, 2022·0 cites·19 claims
- 1976US2020069701A1High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2019·Application pending·0 cites
- 2072US2019209551A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerSPRIASO LLC·Filed 2018·Application pending·0 cites
- 2171US2018055854A1High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Application pending·0 cites
- 2271US2019175615A1Lipobalanced long chain testosterone esters for oral deliveryLIPOCINE INC·Filed 2018·Application pending·0 cites
- 2370US2018125857A1High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Application pending·0 cites
- 2468US2013225544A1Lipobalanced long chain testosterone esters for oral deliveryLIPOCINE INC·Filed 2013·Application pending·0 cites
- 2567US2018071277A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerSPRIASO LLC·Filed 2017·Application pending·0 cites
- 2667US2017007622A1High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2016·Application pending·0 cites
- 2765US2013172381A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerGILIYAR CHANDRASHEKAR·Filed 2012·Application pending·0 cites
- 2865US2019388434A1(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and UseLIPOCINE INC·Filed 2019·Application pending·0 cites
- 2963US2016256454A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerSPRIASO LLC·Filed 2016·Application pending·0 cites
- 3063US2015320686A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerGILIYAR CHANDRASHEKAR·Filed 2015·Application pending·0 cites
- 3163US2015320765A1High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2015·Application pending·0 cites
- 3260US2018153904A1High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2017·Application pending·0 cites
- 3359US2018104257A1(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and UseLIPOCINE INC·Filed 2017·Application pending·0 cites
- 3453US2012148675A1Testosterone undecanoate compositionsCHICKMATH BASAWARAJ·Filed 2010·Application pending·0 cites
- 3545US2016193228A1Lipobalanced long chain testosterone esters for oral deliveryLIPOCINE INC·Filed 2016·Application pending·0 cites
- 3645US2016193227A1Lipobalanced long chain testosterone esters for oral deliveryLIPOCINE INC·Filed 2016·Application pending·0 cites
- 3744US2012135074A1High-Strength Testosterone Undecanoate CompositionsGILIYAR CHANDRASHEKAR·Filed 2010·Application pending·0 cites
- 3843US2016367569A1High-strength testosterone undecanoate compositionsLIPOCINE INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →